Skip to main navigation

Top Links - Left

BioNTech.com Newsroom Investors Healthcare Professionals

Language switcher (Content)

English
German

Top Links - Right Connect

Main Navigation

Events & Presentations

Financials

Quarterly Reports

Financial Calendar

Corporate Governance

Stock Info

Stock Quote & Chart

Analyst Coverage

Shareholder Fraud Warning

Share Repurchase Program

Dividend Information

Annual Information Statements

Annual General Meeting

Annual General Meeting 2024

Annual General Meeting Archive

Healthcare Professionals

Breadcrumb

Investors
Events & Presentations
Event Details

Event Details

Update on COVID-19 Vaccine Program Press Conference

December 2, 2020

Click here for webcast

Supporting Materials

Update on COVID-19 Vaccine Program Press Conference 7.2 MB

BioNTech SE

An der Goldgrube 12

55131 Mainz, Germany

T: +49 6131 9084-0

F: +49 6131 9084-2121

service@biontech.de

Company

About Research & Innovation Pipeline Manufacturing Careers Covid-19

Quick Links

Newsroom Investors Healthcare Professionals Connect

Footer Links - Bottom Terms of Use General Terms and Conditions General Conditions of Purchase Data Privacy Statement Adverse Event Reporting Imprint Cookie Settings

Footer Social Links

© 2024 BioNTech
All rights reserved